{
  "query": "absolute predicted relative baseline",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT01335477",
          "briefTitle": "Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-05"
          },
          "completionDateStruct": {
            "date": "2013-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 551,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05129475",
          "briefTitle": "Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy Participants"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00885365",
          "briefTitle": "A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-04"
          },
          "completionDateStruct": {
            "date": "2010-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 324,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05238675",
          "briefTitle": "A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bronchiectasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 322,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07230288",
          "briefTitle": "Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 165,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01970865",
          "briefTitle": "A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 364,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04882917",
          "briefTitle": "First-in-human Study of M4076 in Advanced Solid Tumors (DDRiver Solid Tumors 410)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06819839",
          "briefTitle": "Community-led Strategy to Reduce Cardiovascular Disease Risk Among Conflict-affected Populations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cardiovascular Diseases", "Hypertension", "Diabetes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 213,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06099353",
          "briefTitle": "Healthy Living With Online suPport & Education for Cardiovascular Disease in the Primary Care Setting"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cardiovascular Diseases (CVD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01807923",
          "briefTitle": "A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05"
          },
          "completionDateStruct": {
            "date": "2014-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis, Homozygous for the F508del CFTR Mutation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 559,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05133271",
          "briefTitle": "Prediction of Maternal Arterial Hypotension After Spinal Anesthesia by Passive Leg Raise Test."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cesarean", "Spinal Anesthesia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02745145",
          "briefTitle": "Abituzumab in SSc-ILD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Sclerosis-associated Interstitial Lung Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03150719",
          "briefTitle": "A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-08-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01180634",
          "briefTitle": "MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-05-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 330,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01775137",
          "briefTitle": "Ext. Long-term Safety Study in CF Patients: Single Arm TIP"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02"
          },
          "completionDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Long-term Safety of TIP"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04594707",
          "briefTitle": "A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 117,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03385668",
          "briefTitle": "Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04805086",
          "briefTitle": "The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-03-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pulmonary Fibrosis", "Interstitial Lung Disease", "Covid19"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04609904",
          "briefTitle": "Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2187,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05559580",
          "briefTitle": "A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Scleroderma, Systemic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 214,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02514473",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07"
          },
          "completionDateStruct": {
            "date": "2016-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 206,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "11 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03735121",
          "briefTitle": "A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 438,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02878161",
          "briefTitle": "Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From \"Real World\""
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01"
          },
          "completionDateStruct": {
            "date": "2019-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04186546",
          "briefTitle": "Zephyr Valve Registry (ZEVR)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Emphysema"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04300478",
          "briefTitle": "Appetite and Exercise in Breast Cancer Survivors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Overweight", "Breast Cancer", "Obesity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03403348",
          "briefTitle": "A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07201922",
          "briefTitle": "A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-23",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-05-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Familial Pulmonary Fibrosis", "Interstitial Lung Abnormalities", "Interstitial Lung Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02025205",
          "briefTitle": "Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COPD Patients With Homogeneous Emphysema", "Endoscopic Lung Volume Reduction With Endobronchial Valve"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 93,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01069705",
          "briefTitle": "Second Open Label Extension to Bridging Study CTBM100C2303"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-02-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-03-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pulmonary Infections", "Pseudomonas Aeruginosa"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05994963",
          "briefTitle": "A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06025578",
          "briefTitle": "A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-27",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Progressive Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1092,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06874387",
          "briefTitle": "Investigating the Combined Effects of Intermittent Hypoxia and Exercise on Cognitive and Cerebral Function in Middle-Aged Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cognitive Ability, General", "Brain Health", "Cerebral Oxygenation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 176,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02004704",
          "briefTitle": "A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sphingomyelin Lipidosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01807949",
          "briefTitle": "A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2014-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis, Homozygous for the F508del CFTR Mutation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 563,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02999178",
          "briefTitle": "Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-08-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Diseases, Interstitial"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 663,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02871778",
          "briefTitle": "Clearing Lungs With ENaC Inhibition in Primary Ciliary Dyskinesia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-11-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Ciliary Dyskinesia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05938920",
          "briefTitle": "Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis (IPF)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04623879",
          "briefTitle": "Real Life Evaluation of the Multi-organ Effects of Lumacaftor/Ivacaftor on F508del Homozygous Cystic Fibrosis Patients."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05067517",
          "briefTitle": "Efficacy & Safety of Nintedanib in Patients With Progressive Fibrosing Coal Mine Dust-Induced Interstitial Lung Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Progressive Fibrosing Interstitial Lung Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01508936",
          "briefTitle": "Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02"
          },
          "completionDateStruct": {
            "date": "2013-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eosinophilic Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 511,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00558844",
          "briefTitle": "Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-01"
          },
          "completionDateStruct": {
            "date": "2009-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00950300",
          "briefTitle": "A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-10-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 596,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02370667",
          "briefTitle": "A Biomechanical Exercise Program for Knee OA"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08"
          },
          "completionDateStruct": {
            "date": "2016-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteoarthritis, Knee"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02609672",
          "briefTitle": "Resilience for Older Workers With OA Through Exercise"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08"
          },
          "completionDateStruct": {
            "date": "2016-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Osteoarthritis, Knee", "Osteoarthritis, Hip"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06165978",
          "briefTitle": "Physical Activity Coaching in Patients with Post-COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Post-COVID-19 Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 162,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06884358",
          "briefTitle": "Functional Capacity in Anderson-Fabry Disease Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Anderson-Fabry Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06724315",
          "briefTitle": "Prospective and Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Brazil (SCOPe)."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COPD (Chronic Obstructive Pulmonary Disease)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 693,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00777296",
          "briefTitle": "Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-02-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00514683",
          "briefTitle": "Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-08"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 432,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05857644",
          "briefTitle": "A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Liver Diseases", "Hepatic Impairment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06478706",
          "briefTitle": "A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 57,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05767528",
          "briefTitle": "Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Muscle-Invasive Bladder Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02070744",
          "briefTitle": "Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03"
          },
          "completionDateStruct": {
            "date": "2016-05-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04538079",
          "briefTitle": "Non-invasive Objective Assessment of Hemodynamics in Preterm Neonates"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hypotension and Shock", "Hypoperfusion", "Hemodynamic Instability", "Intraventricular Hemorrhage", "Cardiac Function", "Circulatory Transition"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "1 Minute",
          "maximumAge": "20 Hours"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04579393",
          "briefTitle": "Fostamatinib for Hospitalized Adults With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronavirus Disease 2019"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 59,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01335464",
          "briefTitle": "Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-04"
          },
          "completionDateStruct": {
            "date": "2013-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 515,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03692481",
          "briefTitle": "Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving Pirfenidone"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06003426",
          "briefTitle": "A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1255,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02057458",
          "briefTitle": "Blood Flow and Vascular Function in Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04609878",
          "briefTitle": "Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2274,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07080125",
          "briefTitle": "A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2033-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Interstitial Lung Diseases", "Systemic Sclerosis Associated Interstitial Lung Disease"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04830618",
          "briefTitle": "Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Metachronous Neoplasm", "Gastric Cancer", "Gastric Neoplasm", "Aberrant DNA Methylation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04418791",
          "briefTitle": "Modified Intermittent Fasting in Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Psoriasis Vulgaris", "Psoriasis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05785624",
          "briefTitle": "A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Idiopathic Pulmonary Fibrosis", "Systemic Sclerosis With Lung Involvement"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 320,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01459653",
          "briefTitle": "Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-03"
          },
          "completionDateStruct": {
            "date": "2013-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Febrile Neutropenia", "Cancer", "Breast Cancer", "Ovarian Cancer", "Lung Cancer", "Prostate Cancer", "Multiple Myeloma", "Bladder Cancer", "B-cell Lymphoma"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1496,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05510245",
          "briefTitle": "A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Type 2 Diabetes", "Renal Impairment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04683029",
          "briefTitle": "A Study of Guselkumab in Participants With Systemic Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Scleroderma, Systemic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05785065",
          "briefTitle": "Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Systemic Sclerosis With Lung Involvement", "Systemic Sclerosis", "Interstitial Lung Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06507475",
          "briefTitle": "Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 209,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01629667",
          "briefTitle": "A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-10"
          },
          "completionDateStruct": {
            "date": "2016-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 409,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02589236",
          "briefTitle": "Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 138,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00812929",
          "briefTitle": "A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-12-01"
          },
          "completionDateStruct": {
            "date": "2009-07-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02744053",
          "briefTitle": "DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Estrogen Receptor Negative", "HER2/Neu Negative", "Progesterone Receptor Negative", "Triple-Negative Breast Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 96,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02449031",
          "briefTitle": "Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pseudomonas Aeruginosa in Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 409,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06217172",
          "briefTitle": "RHEUPP - A Rheumatological Follow-up Management App"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 88,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02951195",
          "briefTitle": "A Study Evaluating the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01362244",
          "briefTitle": "Mepolizumab in Nasal Polyposis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-12-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Nasal Polyps"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 109,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06504589",
          "briefTitle": "A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-08-14",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02516410",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08"
          },
          "completionDateStruct": {
            "date": "2016-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 168,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01580215",
          "briefTitle": "Long Term Follow up Investigation of Endobronchial Valves in Emphysema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2016-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Emphysema"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 628,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04543188",
          "briefTitle": "A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malignant Melanoma", "Carcinoma, Non-Small-Cell Lung", "Brain Neoplasms, Primary", "Brain Neoplasms", "Malignant Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 65,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02139306",
          "briefTitle": "Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 279,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03592368",
          "briefTitle": "Hostile Interpretation Bias Training to Treat Irritability"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Irritable Mood", "Mood Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 97,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02709109",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02"
          },
          "completionDateStruct": {
            "date": "2017-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 147,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01844778",
          "briefTitle": "Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-08"
          },
          "completionDateStruct": {
            "date": "2015-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02762006",
          "briefTitle": "Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Renal Cell Carcinoma", "Kidney Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03037385",
          "briefTitle": "Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["RET-altered Non Small Cell Lung Cancer", "Medullary Thyroid Cancer", "RET-altered Papillary Thyroid Cancer", "RET-altered Colon Cancer", "RET-altered Solid Tumors", "Lung Neoplasm", "Carcinoma, Non-Small-Cell Lung", "Thyroid Diseases", "Thyroid Neoplasm", "Thyroid Cancer, Papillary", "Carcinoma, Neuroendocrine", "Respiratory Tract Neoplasms", "Thoracic Neoplasms", "Neoplasms by Site", "Neoplasms", "Lung Diseases", "Respiratory Tract Disease", "Carcinoma, Bronchogenic", "Bronchial Neoplasms", "Endocrine System Diseases", "Endocrine Gland Neoplasm", "Head and Neck Neoplasms", "Adenocarcinoma, Papillary", "Adenocarcinoma", "Carcinoma", "Neoplasms, Glandular and Epithelial", "Neoplasms by Histologic Type", "Neuroendocrine Tumors", "Neuroectodermal Tumors", "Neoplasms, Germ Cell and Embryonal", "Neoplasms, Nerve Tissue", "Colonic Neoplasms", "Colorectal Neoplasms", "Intestinal Neoplasms", "Gastrointestinal Neoplasms", "Digestive System Neoplasm", "Digestive System Disease", "Gastrointestinal Disease", "Colonic Diseases", "Intestinal Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 590,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04322539",
          "briefTitle": "A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Colorectal Cancer", "Metastatic Colon Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 691,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02178930",
          "briefTitle": "HealthMap: an Interactive Health Plan Randomised Trial to Prevent Cardiovascular Disease in People With HIV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV", "Cardiovascular Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 731,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02611661",
          "briefTitle": "Local Ablative Strategies After Endovascular Radioembolization"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03969888",
          "briefTitle": "A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02038777",
          "briefTitle": "A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02759562",
          "briefTitle": "Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06474273",
          "briefTitle": "TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Rejection; Transplant, Kidney", "Rejection; Transplant, Pancreas"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 540,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03905642",
          "briefTitle": "Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-11-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02412111",
          "briefTitle": "A Phase 3 Study of Tezacaftor (VX-661) in Combination With Ivacaftor (VX-770) in Subjects Aged 12 Years and Older With Cystic Fibrosis (CF), Who Have One F508del-CFTR Mutation and a Second Mutation That Has Been Demonstrated to be Clinically Responsive to Ivacaftor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 156,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06728384",
          "briefTitle": "Remodeling of Distal Coronary Vessel in Chronic Total Occlusions: Prediction Based on Hemodynamic Coronary Parameters"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Total Occlusion (CTO)", "Percutaneous Coronary Intervention (PCI)", "Fractional Flow Reserve", "Quantitative Coronary Analysis", "Absolute Flow Measurement", "Optical Coherence Tomography (OCT)"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01769196",
          "briefTitle": "Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-02-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 544,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01931839",
          "briefTitle": "A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10"
          },
          "completionDateStruct": {
            "date": "2016-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1164,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00883181",
          "briefTitle": "A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-11"
          },
          "completionDateStruct": {
            "date": "2014-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Cancer", "Non-Small Cell Lung Cancer", "Ovarian Cancer", "Small Cell Lung Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1370,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT04674137",
          "briefTitle": "XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Bronchial Asthma", "Eosinophilic Asthma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05270759",
          "briefTitle": "Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Kidney Injury", "Chronic Kidney Disease Stage 5 on Dialysis", "Chronic Kidney Failure", "Intradialytic Hypotension", "Fluid Overload"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 93,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07160972",
          "briefTitle": "AI-Based Lifestyle Guidance Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03921866",
          "briefTitle": "UK Ibrance Patient Program (IPP) Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HR+/HER2- Locally Advanced, Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 191,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05943535",
          "briefTitle": "Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Progressive Pulmonary Fibrosis", "Interstitial Lung Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 698,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00982930",
          "briefTitle": "Open Label Extension to Bridging Study CTBM100C2303"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-10-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pseudomonas Aeruginosa", "Cystic Fibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01270464",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02"
          },
          "completionDateStruct": {
            "date": "2013-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eosinophilic Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 315,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03813160",
          "briefTitle": "Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dermatomyositis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 176,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06455462",
          "briefTitle": "Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Asthma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 350,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06238622",
          "briefTitle": "A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Idiopathic Pulmonary Fibrosis", "Progressive Pulmonary Fibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1700,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05195918",
          "briefTitle": "Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-21",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04708782",
          "briefTitle": "Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Idiopathic Pulmonary Fibrosis", "Interstitial Lung Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 576,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02597933",
          "briefTitle": "A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-11-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Scleroderma, Systemic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 580,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00689728",
          "briefTitle": "A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06"
          },
          "completionDateStruct": {
            "date": "2010-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03265288",
          "briefTitle": "Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 166,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02978586",
          "briefTitle": "A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate-specific Membrane Antigen Positive Tumors", "Prostate Cancer", "Breast Cancer", "Lung Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05255991",
          "briefTitle": "Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Idiopathic Pulmonary Fibrosis", "Interstitial Lung Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 597,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06264674",
          "briefTitle": "Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS)."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 836,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02808871",
          "briefTitle": "Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis Interstitial Lung Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01715896",
          "briefTitle": "A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03"
          },
          "completionDateStruct": {
            "date": "2015-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 215,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02443688",
          "briefTitle": "EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05446142",
          "briefTitle": "A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02565914",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Participants With Cystic Fibrosis Who Have an F508del-CFTR Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1131,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01290887",
          "briefTitle": "Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06"
          },
          "completionDateStruct": {
            "date": "2015-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eosinophilic Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1052,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03797404",
          "briefTitle": "Airway Remodeling During Mepolizumab Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06317285",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 158,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01225211",
          "briefTitle": "Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10"
          },
          "completionDateStruct": {
            "date": "2014-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 312,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05799755",
          "briefTitle": "Myositis Interstitial Lung Disease Nintedanib Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myositis Associated Interstitial Lund Disease (MA-ILD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02894099",
          "briefTitle": "Cardiovascular Risk in Sedentary Elderly During Prolonged Sitting Time Versus Intermittent Sitting Time"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sedentary Lifestyle"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05649722",
          "briefTitle": "An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-14",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pulmonary Hypertension", "Interstitial Lung Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02875366",
          "briefTitle": "A Study of the Effects of Lumacaftor/Ivacaftor (LUM/IVA) on Exercise Tolerance in Subjects With Cystic Fibrosis (CF), Homozygous for the F508del-CFTR Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03538301",
          "briefTitle": "JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02724527",
          "briefTitle": "Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04"
          },
          "completionDateStruct": {
            "date": "2017-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01706926",
          "briefTitle": "A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08"
          },
          "completionDateStruct": {
            "date": "2014-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 420,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02485938",
          "briefTitle": "HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-09-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Duchenne Muscular Dystrophy", "Cardiomyopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07124949",
          "briefTitle": "Chinese Migrant Population Health Cohort"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cardiovascular Diseases", "Metabolic Disorders", "Ageing and Geriatric Health", "Climate Adaptation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 26000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05755308",
          "briefTitle": "Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 114,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07210008",
          "briefTitle": "\"Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis\""
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-06-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hypersensitivity Pneumonitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02347657",
          "briefTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 510,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07047690",
          "briefTitle": "A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-07-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 162,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04800211",
          "briefTitle": "Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-11-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Tobacco Use"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03181932",
          "briefTitle": "AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["MRSA", "Cystic Fibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 188,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04308681",
          "briefTitle": "A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 403,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05878717",
          "briefTitle": "A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Systemic Sclerosis Associated Interstitial Lung Disease", "Scleroderma, Systemic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05259449",
          "briefTitle": "Efficacy of Educational Nutrition and Exercise on the Regulation of Appetite Through Exosomes in Type 2 Diabetics"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 146,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02853578",
          "briefTitle": "Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00730158",
          "briefTitle": "A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-12"
          },
          "completionDateStruct": {
            "date": "2018-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06698042",
          "briefTitle": "A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-02-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lung Cancer", "Non-Small Cell Lung Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05777746",
          "briefTitle": "The Effect of an Online Plant-Based Dietary Program on Cardiovascular Risk Factors in Persons With Type 2 Diabetes Mellitus: A Randomized Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus, Type 2", "Diet, Vegetarian", "Diet, Vegan", "Cardiometabolic Risk Factors", "Cholesterol, LDL", "Blood Pressure", "Glycemic Control", "Diet Therapy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04853368",
          "briefTitle": "Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis (CF)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02498535",
          "briefTitle": "Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04844359",
          "briefTitle": "A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hypersensitivity Pneumonitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 137,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07161193",
          "briefTitle": "Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-11-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Autoimmune Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00918957",
          "briefTitle": "A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-06"
          },
          "completionDateStruct": {
            "date": "2011-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06572384",
          "briefTitle": "A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-13",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Diseases, Interstitial"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 440,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03717012",
          "briefTitle": "Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02392234",
          "briefTitle": "A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03"
          },
          "completionDateStruct": {
            "date": "2017-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 248,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      }
    ]
  }
}
